---
title: "ImmuPharma Raises GBP3 Million via Share Placing, Subscription"
date: "2025-02-13 18:28:43"
summary: "ImmuPharma said Thursday it completed an equity fundraising of 2.9 million pounds sterling through an oversubscribed share placing and subscription. The specialist drug discovery company raised 1 million pounds through the issuance of 27,586,667 new ordinary shares and 1.9 million pounds through a subscription from 6.5% stakeholder Lanstead Capital Investors...."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

ImmuPharma said Thursday it completed an equity fundraising of 2.9 million pounds sterling through an oversubscribed share placing and subscription.

The specialist drug discovery company raised 1 million pounds through the issuance of 27,586,667 new ordinary shares and 1.9 million pounds through a subscription from 6.5% stakeholder Lanstead Capital Investors.

ImmuPharma said the proceeds will be used to fund the P140 autoimmune technology platform, balance sheet strengthening and for general working capital.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250213:G2467486:0/)
